SYNGAP1 and psychiatric disorder: With Agap2, Kalirin, and Syngap1 being implicated in contributing to the risk of psychiatric disease, we also show that they interact with and cluster proteins involved in autism spectrum disorder (ASD), schizophrenia (SCZ), and intellectual disability (ID).